Universe Pharmaceuticals (UPC) Other Non-Current Assets (2020 - 2024)

Universe Pharmaceuticals has disclosed Other Non-Current Assets across 4 years of filings, most recently posting $96141.0 for Q1 2024.

• Other Non-Current Assets for Q1 2024 came in at $96141.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2024 was $96141.0 (changed N/A YoY), and the FY2023 annual result was $35864.0, down 98.53% from the prior year.
• Other Non-Current Assets came in at $96141.0 for Q1 2024 at Universe Pharmaceuticals, up from $35864.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $443.7 billion in Q3 2020 to a low of $35864.0 in Q3 2023.
• The 4-year median for Other Non-Current Assets is $1.3 million (2022), against an average of $110.9 billion.
• Peak annual rise in Other Non-Current Assets reached 98.53% in 2023, while the deepest fall reached 98.53% in 2023.
• Universe Pharmaceuticals' Other Non-Current Assets stood at $443.7 billion in 2020, then tumbled by 100.0% to $2.4 million in 2022, then plunged by 98.53% to $35864.0 in 2023, then soared by 168.07% to $96141.0 in 2024.
• The last three Other Non-Current Assets figures came in at $96141.0 (Q1 2024), $35864.0 (Q3 2023), and $2.4 million (Q3 2022), per Business Quant data.